INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer drug combo study halted early
Disease control TerminatedThis study tested a new drug called SD-101, given directly into the liver's blood supply, along with standard immunotherapy drugs, for people with two types of liver cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma). The goal was to find a safe dose and see if…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New scan may help doctors plan better liver cancer treatments
Knowledge-focused TerminatedThis study tested a special scan (SPECT/CT) to measure how well the liver works in 41 people with liver cancer who were getting radiation or surgery. The goal was to see if the scan could track changes in healthy liver tissue before, during, and after treatment. The study was sto…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC